Evidence map›Paper›PMID 20687924›Full record

Trial reportBMC public health2010

The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trial.

Laura M C Welschen, Sandra D M Bot, Jacqueline M Dekker, Daniëlle R M Timmermans, Trudy van der Weijden, Giel Nijpels

2 registry-linked trialsOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC public health, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06607497 naactive not recruitingnot on this mapstarted 2024, after this paper: background citation

Better Risk Perception Via Patient Similarity to Control Hyperglycemia and Sustained by Telemonitoring

TypeinterventionalSponsorSingHealth PolyclinicsRan2024 to 2026Enrolled360ConditionsDiabetes Mellitus, Type 2ArmsIntervention using an AI enabled risk communication tool (PERDICT.AI), Telemonitoring with Primary Tech Enhanced Care (PTEC-DM)
NCT06837428 nacompletednot on this mapstarted 2023, after this paper: background citation

Peer Comparison-based Risk Communication (PRICOM): A Study Protocol to Evaluate the Feasibility of Delivering a Risk Communication Intervention in the Primary Care Setting for Adults With Type 2 Diabetes Mellitus

TypeinterventionalSponsorSingHealth PolyclinicsRan2023 to 2024Enrolled40ConditionsDiabetes Type 2ArmsPeer comparison-based Risk Communication (PRICOM)
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Risk scoring for the primary prevention of cardiovascular disease.The Cochrane database of systematic reviews · 2017
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Laura M C WelschenDepartment of General Practice, EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, the Netherlands. l.welschen@vumc.nl
Sandra D M Bot
Jacqueline M Dekker
Daniëlle R M Timmermans
Trudy van der Weijden
Giel Nijpels
EMGO Institute for Health and Care Research · NLMaastricht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with type 2 diabetes mellitus (T2DM) have an increased risk to develop severe diabetes related complications, especially cardiovascular disease (CVD). The risk to develop CVD can be estimated by means of risk formulas. However, patients have difficulties to understand the outcomes of these formulas. As a result, they may not recognize the importance of changing lifestyle and taking medication in time. Therefore, it is important to develop risk communication methods, that will improve the patients' understanding of risks associated with having diabetes, which enables them to make informed choices about their diabetes care.The aim of this study is to investigate the effects of an intervention focussed on the communication of the absolute 10-year risk to develop CVD on risk perception, attitude and intention to change lifestyle behaviour in patients with T2DM. The conceptual framework of the intervention is based on the Theory of Planned Behaviour and the Self-regulation Theory.

methodsA randomised controlled trial will be performed in the Diabetes Care System West-Friesland (DCS), a managed care system. Newly referred T2DM patients of the DCS, younger than 75 years will be eligible for the study. The intervention group will be exposed to risk communication on CVD, on top of standard managed care of the DCS. This intervention consists of a simple explanation on the causes and consequences of CVD, and possibilities for prevention. The probabilities of CVD in 10 year will be explained in natural frequencies and visualised by a population diagram. The control group will receive standard managed care. The primary outcome is appropriateness of risk perception. Secondary outcomes are attitude and intention to change lifestyle behaviour and illness perception. Differences between baseline and follow-up (2 and 12 weeks) between groups will be analysed according to the intention-to-treat principle. The study was powered on 120 patients in each group. DISCUSSION: This innovative risk communication method based on two behavioural theories might improve patient's appropriateness of risk perception and attitude concerning lifestyle change. With a better understanding of their CVD risk, patients will be able to make informed choices concerning diabetes care.

trial registrationThe trial is registered as NTR1556 in the Dutch Trial Register.

Indexed as

CommunicationResearch DesignRisk AssessmentCardiovascular DiseasesDiabetes Mellitus, Type 2FemaleHumansMaleNetherlandsRisk Reduction BehaviorSurveys and Questionnaires

Identifiers

PMID20687924
PMCPMC2922111
OpenAlexW2033890902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.